Effect of delayed treatment on survival of patients with head and neck squamous cell cancer
Prolonged treatment delays were associated with an increased risk of mortality in patients with lip/oral cavity, oropharyngeal, and laryngeal cancers, and should be focused on in order to improve patient prognosis.
The impact of prolonged treatment delays on the survival outcomes of patients with head and neck squamous cell cancer (HNSCC) remains controversial. Patients were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The association between diagnosis-to-treatment interval (DTI) and survival was assessed using Cox proportional hazards models and competing risk regression.4700 (6.1%) experienced treatment delays and 28,934 (37.8%) died due to cancer-specific causes. Treatment delays were associated with a worse overall survival (OS) and cancer-specific survival (CSS) of patients with cancer in the lip/oral cavity (OS: adjusted hazard ratio [aHR] = 1.16, 95% confidence interval [CI]: 1.08–1.24; CSS: aHR = 1.15, 95% CI 1.06–1.24), oropharynx (OS: aHR = 1.19, 95% CI 1.12–1.28; CSS: aHR = 1.19, 95% CI 1.10–1.28), and larynx (OS: aHR = 1.21, 95% CI 1.13–1.30; CSS: aHR = 1.21, 95% CI 1.10–1.33). However, treatment delay did not find significance on OS and CSS in patients with cancers of the hypopharynx, nasopharynx, nasal cavity and sinuses, or salivary glands at the time cutoff of 2 months for delayed treatment. Prolonged treatment delays were associated with an increased risk of mortality in patients with lip/oral cavity, oropharyngeal, and laryngeal cancers, and should be focused on in order to improve patient prognosis.
Early initiation of treatment is critical for maintaining survival benefits in HNSCC, especially for lip/oral cavity, oropharyngeal, and laryngeal subtypes. This study quantifies the adverse impact of delays exceeding two months, underscoring the need for healthcare systems to prioritize timely management to improve overall and cancer‑specific survival outcomes.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Spatial Profiling of the Head and Neck Squamous Cell Carcinoma Microenvironment: Reshaping Our Understanding and Therapeutic Opportunities
- Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer
- Review Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review
- Preclinical models in head and neck squamous cell carcinoma
- CAR-Based Cell Therapy in Head and Neck Cancer: A Comprehensive Review on Clinical Applicability